Fingerprint
Dive into the research topics of 'Multi-institutional phase 2 study of the farnesyltransferase inhibitor tipifarnib (R115777) in patients with relapsed and refractory lymphomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically